AU2001263288A1 - Crf receptor antagonists - Google Patents
Crf receptor antagonistsInfo
- Publication number
- AU2001263288A1 AU2001263288A1 AU2001263288A AU6328801A AU2001263288A1 AU 2001263288 A1 AU2001263288 A1 AU 2001263288A1 AU 2001263288 A AU2001263288 A AU 2001263288A AU 6328801 A AU6328801 A AU 6328801A AU 2001263288 A1 AU2001263288 A1 AU 2001263288A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonists
- crf receptor
- crf
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/16—Peri-condensed systems
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20561400P | 2000-05-18 | 2000-05-18 | |
US20560700P | 2000-05-18 | 2000-05-18 | |
US20561100P | 2000-05-18 | 2000-05-18 | |
US60205607 | 2000-05-18 | ||
US60205614 | 2000-05-18 | ||
US60205611 | 2000-05-18 | ||
PCT/US2001/016202 WO2001087892A1 (en) | 2000-05-18 | 2001-05-18 | Crf receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001263288A1 true AU2001263288A1 (en) | 2001-11-26 |
Family
ID=27394819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001263288A Abandoned AU2001263288A1 (en) | 2000-05-18 | 2001-05-18 | Crf receptor antagonists |
Country Status (5)
Country | Link |
---|---|
US (2) | US6440960B1 (en) |
EP (1) | EP1287002A1 (en) |
JP (1) | JP2003533530A (en) |
AU (1) | AU2001263288A1 (en) |
WO (1) | WO2001087892A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7273871B2 (en) * | 2001-07-17 | 2007-09-25 | Sb Pharmco Puerto Rico Inc. | Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists |
DK1599468T3 (en) | 2003-01-14 | 2008-02-04 | Arena Pharm Inc | 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prevention and treatment of disorders associated therewith such as diabetes and hyperglycemia |
EP2287166A3 (en) | 2003-07-14 | 2011-06-22 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
US20060024661A1 (en) * | 2003-07-30 | 2006-02-02 | The Regents Of The University Of California | Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2 |
SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EP3242666A1 (en) | 2015-01-06 | 2017-11-15 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
JP6838744B2 (en) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (R) -2- (7- (4-cyclopentyl-3- (trifluoromethyl) benzyloxy) -1,2,3,4-tetrahydrocyclopenta [b] indole-for use in S1P1 receptor-related disorders Crystalline L-arginine salt of 3-yl) acetic acid (Compound 1) |
KR20190116416A (en) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | Compounds and Methods for Treating Primary Bile Cholangitis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA973884B (en) * | 1996-05-23 | 1998-11-06 | Du Pont Merck Pharma | Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
CZ68199A3 (en) | 1996-08-28 | 1999-11-17 | Pfizer Inc. | 6,5-heterobicyclic derivatives, pharmaceutical composition based thereon and method of treating diseases |
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
EP1129091B1 (en) * | 1998-11-12 | 2002-10-02 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
-
2001
- 2001-05-18 US US09/861,195 patent/US6440960B1/en not_active Expired - Fee Related
- 2001-05-18 AU AU2001263288A patent/AU2001263288A1/en not_active Abandoned
- 2001-05-18 EP EP01937569A patent/EP1287002A1/en not_active Withdrawn
- 2001-05-18 JP JP2001584286A patent/JP2003533530A/en not_active Withdrawn
- 2001-05-18 WO PCT/US2001/016202 patent/WO2001087892A1/en not_active Application Discontinuation
-
2002
- 2002-04-11 US US10/123,076 patent/US20030055050A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020049203A1 (en) | 2002-04-25 |
EP1287002A1 (en) | 2003-03-05 |
US6440960B1 (en) | 2002-08-27 |
US20030055050A1 (en) | 2003-03-20 |
JP2003533530A (en) | 2003-11-11 |
WO2001087892A1 (en) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001255798A1 (en) | Glucagon antagonists | |
AU2001264657A1 (en) | Crf receptor antagonists | |
AU2001250205A1 (en) | Prostaglandin d2 receptor antagonists | |
AU2001273032A1 (en) | Cytokine receptor zcytor17 | |
AU4331500A (en) | Pyrazolotriazines as crf antagonists | |
AU2441801A (en) | Urotensin-ii receptor antagonists | |
AU2001240021A1 (en) | Diazafluorenone il-8 receptor antagonists | |
AU2001245724A1 (en) | Il-8 receptor antagonists | |
AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
AU2001243351A1 (en) | Il-8 receptor antagonists | |
AU2002216079A1 (en) | Bombesin receptor antagonists | |
AU2001240097A1 (en) | G protein-coupled receptors | |
AU2002239506A1 (en) | Urotensin-ii receptor antagonists | |
AU2001263288A1 (en) | Crf receptor antagonists | |
AU2001249573A1 (en) | Chemokine receptor antagonists | |
AU2001241896A1 (en) | Il-8 receptor antagonists | |
AU2001253172A1 (en) | Il-8 receptor antagonists | |
AU2002217095A1 (en) | Bombesin receptor antagonists | |
AU2001245605A1 (en) | Il-8 receptor antagonists | |
AU2001223882A1 (en) | Receptor | |
AUPQ563400A0 (en) | Novel receptor | |
AU2574801A (en) | Selective iGLUR5 receptor antagonists | |
AU2001249922A1 (en) | G protein-coupled receptors | |
AU6051200A (en) | Il-8 receptor antagonists | |
AU2001259322A1 (en) | G protein-coupled receptors |